Cargando…

The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study

RATIONALE: The purpose of this study is to evaluate the single dose effect of intranasal esketamine (84 mg) compared to placebo on on-road driving performance. Mirtazapine (oral, 30 mg) was used as a positive control, as this antidepressant drug is known to negatively affect driving performance. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Loo, Aurora J. A. E., Bervoets, Adriana C., Mooren, Loes, Bouwmeester, Noor H., Garssen, Johan, Zuiker, Rob, van Amerongen, Guido, van Gerven, Joop, Singh, Jaskaran, der Ark, Peter Van, Fedgchin, Maggie, Morrison, Randall, Wajs, Ewa, Verster, Joris C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660834/ https://www.ncbi.nlm.nih.gov/pubmed/28755104 http://dx.doi.org/10.1007/s00213-017-4706-6

Ejemplares similares

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
por: Morrison, Randall L., et al.
Publicado: (2018)

Genome-wide association study and polygenic risk score analysis of esketamine treatment response
por: Li, Qingqin S., et al.
Publicado: (2020)

Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD
por: Williamson, David, et al.
Publicado: (2022)

The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
por: Dijkstra, Francis M, et al.
Publicado: (2022)

Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
por: Doherty, Teodora, et al.
Publicado: (2020)

The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder
por: Daly, Ella J., et al.
Publicado: (2021)

Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data
por: Nijs, Michel, et al.
Publicado: (2020)

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
por: Chen, Guang, et al.
Publicado: (2022)

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2019)

Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
por: Recourt, Kasper, et al.
Publicado: (2019)

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials
por: Saad, Ziad, et al.
Publicado: (2020)

Synthesis of the Humites nMg(2)SiO(4)·Mg(F, OH)(2)
por: Van Valkenburg, A.
Publicado: (1961)

Intranasal esketamine and the dawn of precision psychiatry
por: Watts, Devon, et al.
Publicado: (2021)

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
por: Fedgchin, Maggie, et al.
Publicado: (2019)

Myasthenia gravis: MuSK MG, late-onset MG and ocular MG
por: Deymeer, Feza
Publicado: (2020)

Characteristics of social drinkers with and without a hangover after heavy alcohol consumption
por: Hogewoning, A, et al.
Publicado: (2016)

Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies
por: Doty, Richard L., et al.
Publicado: (2021)

Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers
por: Dijkstra, Francis, et al.
Publicado: (2022)

Quadrupole Moments of $^{29}$Mg and $^{33}$Mg
por: Yordanov, Deyan Todorov, et al.
Publicado: (2019)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

A combined experimental and computational study on the reaction of fluoroarenes with Mg–Mg, Mg–Zn, Mg–Al and Al–Zn bonds
por: Bakewell, Clare, et al.
Publicado: (2018)

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Coulomb excitation of (31)Mg
por: Seidlitz, M, et al.
Publicado: (2011)

Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression
por: Katz, Eva G., et al.
Publicado: (2020)

Evaluation of Mg Compounds as Coating Materials in Mg Batteries
por: Chen, Tina, et al.
Publicado: (2019)

Serum Mg Isotopic Composition Reveals That Mg Dyshomeostasis Remains in Type 1 Diabetes despite the Resolution of Hypomagnesemia
por: Sullivan, Kaj Vaughan, et al.
Publicado: (2023)

Experimentally Observed Nucleation and Growth Behavior of Mg/MgH(2) during De/Hydrogenation of MgH(2)/Mg: A Review
por: Lyu, Jinzhe, et al.
Publicado: (2022)

Mg(2+) Transporters in Digestive Cancers
por: Auwercx, Julie, et al.
Publicado: (2021)

Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single-dose, randomized, and double-blind study
por: Lyngstad, Gaute, et al.
Publicado: (2023)

The Influence of MgH(2) on the Assessment of Electrochemical Data to Predict the Degradation Rate of Mg and Mg Alloys
por: Mueller, Wolf-Dieter, et al.
Publicado: (2014)

Appropriate clinical use of darunavir 800 mg
por: Moorhouse, Michelle A., et al.
Publicado: (2018)

Cardiovascular effect of dental anesthesia with articaine (40 mg with epinefrine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30mg and 20 mg with epinefrine 1 mg%) in medically compromised cardiac patients: A cross-over, randomized, single blinded study
por: Torres-Lagares, Daniel, et al.
Publicado: (2012)

Intranasal Esketamine administration in catatonia: a case report.
por: Romay, J., et al.
Publicado: (2023)

Dissociating the Clinical Role and Economic Value of Intranasal Esketamine
por: Dadiomov, David
Publicado: (2020)

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
por: Dahlöf, Carl, et al.
Publicado: (2004)

A Novel Role for Polycystin-2 (Pkd2) in P. tetraurelia as a Probable Mg(2+) Channel Necessary for Mg(2+)-Induced Behavior
por: Valentine, Megan S., et al.
Publicado: (2019)

From $^{27}$Mg to ${33}$Mg: transition to the "Island of inversion"
por: Yordanov, Deyan
Publicado: (2012)

Defects, dopants and Mg diffusion in MgTiO(3)
por: Kuganathan, Navaratnarajah, et al.
Publicado: (2019)

Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)

Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mj0astgrt707g6e6nmj067t46p